Analysis of OCT1, OCT2 and OCT3 gene polymorphisms among Type 2 diabetes mellitus subjects in Indian ethnicity, Malaysia

Evaluation of rs3088442 G > A SLC22A3 Gene Polymorphism and Role of microRNA 147 in T2DM Groups of Adult Pakistani Population in Response to Metformin

(2018) Sadaf Moeez et al.   Canadian Journal of Diabetes

Predicting type 2 diabetes using genetic and environmental risk factors in a multi-ethnic Malaysian cohort

(2017) N. Abdullah et al.   PUBLIC HEALTH

Allele frequency and genotype distribution of a common variant in the 3´-untranslated region of the SLC22A3 gene in patients with type 2 diabetes: Association with response to metformin

(2016) Abdolkarim Mahrooz et al.   Journal of Research in Medical Sciences

The variant organic cation transporter 2 (OCT2)–T201M contribute to changes in insulin resistance in patients with type 2 diabetes treated with metformin

(2015) Zahra Kashi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Genetic polymorphisms of the organic cation transporter 1 gene (SLC22A1) within the Cape Admixed population of South Africa

(2014) Morne Du Plessis et al.   MOLECULAR BIOLOGY REPORTS

Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine

(2013) Fabian Müller et al.   BIOCHEMICAL PHARMACOLOGY

The Role of Pharmacogenetics in Drug Disposition and Response of Oral Glucose-Lowering Drugs

(2013) N. van Leeuwen et al.   CLINICAL PHARMACOKINETICS

The many faces of diabetes: a disease with increasing heterogeneity

(2013) Tiinamaija Tuomi et al.   LANCET

The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3

(2013) Vivian Massmann et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

The Risk of Type 2 Diabetes in Men Is Synergistically Affected by Parental History of Diabetes and Overweight

(2013) Cecilia Wikner et al.   PLoS One

Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients

(2012) Linda Tarasova et al.   Pharmacogenetics and Genomics

Evaluation of organic cation transporter 3 (SLC22A3) inhibition as a potential mechanism of antidepressant action

(2012) Hao-Jie Zhu et al.   PHARMACOLOGICAL RESEARCH

Disposition of metformin: Variability due to polymorphisms of organic cation transporters

(2011) Oliver Zolk   ANNALS OF MEDICINE

Substrate recognition and translocation by polyspecific organic cation transporters

(2011) Hermann Koepsell   BIOLOGICAL CHEMISTRY

Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations

(2010) J König et al.   BRITISH JOURNAL OF PHARMACOLOGY

Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin

(2010) Ligong Chen et al.   Pharmacogenetics and Genomics

Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver

(2009) Anne T. Nies et al.   HEPATOLOGY

Transcellular transport of organic cations in double-transfected MDCK cells expressing human organic cation transporters hOCT1/hMATE1 and hOCT2/hMATE1

(2008) Tomoko Sato et al.   BIOCHEMICAL PHARMACOLOGY